March 23, 2015
Pfizer Japan said on March 20 its selective serotonin reuptake inhibitor Jzoloft (sertraline) was granted Japanese regulatory approval for an additional indication of post-traumatic stress disorder (PTSD) on the same day. The drug has been on the market for the...read more